The PDE5 inhibitor udenafil ameliorates nonalcoholic fatty liver disease by improving mitochondrial function. Yu HM, Chung HK, Park KS. Biochem Biophys Res Commun 2021;558:57-63.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yu HM, Chung HK, Park KS. The PDE5 inhibitor udenafil ameliorates nonalcoholic fatty liver disease by improving mitochondrial function. Biochem Biophys Res Commun 2021;558:57-63.
PMID: 33895552